EUVIMEDEUVIMED entdecken
Crossref

Evolution, control and success of combination therapy with Ampicilin-sulbactam/Ceftazidime-Avibactam during a Carbapenem-Resistant Acinetobacter baumannii outbreak in burn Intensive Care Unit

Emmanuel Dudoignon, Francois Caméléna, Matthieu Lafaurie, Benjamin Deniau, Maité Chaussard, Maxime Coutrot, Lucie Guillemet, Alexandru Cupaciu, Alexandre Pharaboz, Louis Boutin, Mourad Benyamina, Marc Chaouat und 7 weitere

European Journal of Clinical Microbiology & Infectious Diseases · 2024

DOI: 10.1007/s10096-024-04840-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Emmanuel Dudoignon und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care and Burn Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier St Louis- Lariboisièr…. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections, Disease Outbreaks, Anti-Bacterial Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAcinetobacter InfectionsDisease OutbreaksAnti-Bacterial AgentsAzabicyclo CompoundsIntensive Care UnitsSulbactamDrug CombinationsCarbapenemsCeftazidimeHumansMaleFemaleMiddle AgedAdultBurnsDrug Therapy, CombinationTreatment OutcomeAgedCross InfectionDrug Resistance, Multiple, Bacterialbeta-LactamasesBurn Units

Stichwörter der Autor:innen

Ampicillin-sulbactamAntibiotic resistanceBurnCarbapenem-resistant Acinetobacter baumanniiCefiderocolOutbreakWhole-genome sequencing

Substanzen

Anti-Bacterial AgentsAzabicyclo CompoundsSulbactamDrug CombinationsCarbapenemsCeftazidimeavibactam, ceftazidime drug combinationbeta-Lactamases

Autor:innen und Institutionen

  • Department of Anesthesiology and Critical Care and Burn Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier St Louis- Lariboisière, 1, avenue Claude Vellefaux, Paris, 75010, France. emmanuel.dudoigno…
  • University of Paris Cité, Paris, France. emmanuel.dudoignon@aphp.fr.
  • Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM UMR-S 942 Mascot, Lariboisière Hospital, Paris, France. emmanuel.dudoignon@aphp.fr.
  • INI-CRCT Network, Nancy, France. emmanuel.dudoignon@aphp.fr.
  • FHU PROMICE, Paris, France. emmanuel.dudoignon@aphp.fr.
  • University of Paris Cité, Paris, France.

Zitieren

APA

Dudoignon, E., Caméléna, F., Lafaurie, M., Deniau, B., Chaussard, M., Coutrot, M., Guillemet, L., Cupaciu, A., Pharaboz, A., Boutin, L., Benyamina, M., Chaouat, M., Mimoun, M., Merimèche, M., Mebazaa, A., Plaud, B., Berçot, B., Dépret, F., & Mellon, G. (2024). Evolution, control and success of combination therapy with Ampicilin-sulbactam/Ceftazidime-Avibactam during a Carbapenem-Resistant Acinetobacter baumannii outbreak in burn Intensive Care Unit. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04840-9

Vancouver

Dudoignon E, Caméléna F, Lafaurie M, Deniau B, Chaussard M, Coutrot M, et al. Evolution, control and success of combination therapy with Ampicilin-sulbactam/Ceftazidime-Avibactam during a Carbapenem-Resistant Acinetobacter baumannii outbreak in burn Intensive Care Unit. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04840-9

BibTeX
@article{Dudoignon2024,
  author = {Dudoignon, Emmanuel and Caméléna, Francois and Lafaurie, Matthieu and Deniau, Benjamin and Chaussard, Maité and Coutrot, Maxime and Guillemet, Lucie and Cupaciu, Alexandru and Pharaboz, Alexandre and Boutin, Louis and Benyamina, Mourad and Chaouat, Marc and Mimoun, Maurice and Merimèche, Manel and Mebazaa, Alexandre and Plaud, Benoit and Berçot, Béatrice and Dépret, François and Mellon, Guillaume},
  title = {Evolution, control and success of combination therapy with Ampicilin-sulbactam/Ceftazidime-Avibactam during a Carbapenem-Resistant Acinetobacter baumannii outbreak in burn Intensive Care Unit},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  doi = {10.1007/s10096-024-04840-9}
}
Kostenlos starten →